Long-term follow-up in such diseases as psoriasis and atopic dermatitis are reinforcing the empiric impression that a ‘super ...
HOUSTON -- Complete response (CR) rates in relapsed/refractory NPM1-mutated acute myeloid leukemia (AML) doubled historical rates in a preliminary study of an investigational menin inhibitor. A pooled ...
Zacks Investment Research on MSN
BMY Reports Positive Data From a Late-Stage Multiple Myeloma Study
Bristol Myers Squibb BMY announced positive data from the late-stage study on iberdomide in patients with relapsed or ...
Sommige resultaten zijn verborgen omdat ze mogelijk niet toegankelijk zijn voor u.
Niet-toegankelijke resultaten weergeven
Feedback